A video published on YouTube has reignited debate about McAllen, a city in Texas often cited in American rankings related to ...

Childhood obesity rates have skyrocketed over 300% since the 1970s, now affecting 21% of children. Dr. Marc Siegel explains ...

June 29, 2026. More for Yo ...

Most websites selling GLP-1 receptor agonists prescribe medications without any direct interaction with a health care ...

Rates of chronic disease, obesity and stress continue to rise across America. Experts warn that some of the healthiest habits ...

Five years after Wegovy’s FDA approval, the obesity drug market has evolved rapidly. Novo Nordisk and Eli Lilly introduced GLP-1 pills to compete with the in-demand weight loss shots. Eli Lilly’s next ...

Adverts for Domino’s, KFC and Burger King cleared despite junk food crackdown - ...

The Medicare GLP-1 Bridge Program has opened and will remain open through 2027, giving some Medicare beneficiaries greater ...

Dave Ricks steered the 150-year-old drug giant to a $1 trillion market cap. Can he defeat pharma’s boom and bust cycle?

Novo Nordisk offers dividend income and MASH upside versus Lilly's high‑growth obesity lead.

The researchers were distributing an editorial from an American Diabetes Association journal during the group’s annual meeting when they were escorted out by local police and security.

This was exactly what I wanted, but I wanted this over three months. But every time I looked in the mirror, my body was ...